Status:
UNKNOWN
Paracetamol Discontinuation in the Elderly After Long-term Consumption
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Conditions:
Pain, Chronic
Pain, Medication
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
To investigate if long-term treatment of paracetamol can be discontinued without no worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatment...
Detailed Description
Aim: To investigate if long-term treatment of paracetamol can be discontinued without worsening on pain, health-related quality-of-life and level of function compared to continuing paracetamol treatme...
Eligibility Criteria
Inclusion
- 65 years or more
- Regular daily users of 3 to 4 grams of paracetamol for at least 6 months prior to enrollment
Exclusion
- Malignant pain cf. their medical records
- Patients using other regular analgesics cf. indication on prescription
- Patients receiving paracetamol tablets with modified release or sustained release
- Patients in warfarin treatment
- Patients with terminal illnesses, cf. their medical records.
- Patients receiving dosages dispensed by their pharmacy
- Mini-Mental State Examination (MMSE) score less than 25
- Patients with or suspected to have COVID-19.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT04523740
Start Date
August 1 2020
End Date
December 1 2021
Last Update
August 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of clinical pharmacology
Copenhagen, Bispebjerg, Denmark, 2400